These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18841719)

  • 21. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
    Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug companies agree to cut price of HPV vaccine to developing countries to increase accessibility.
    Gulland A
    BMJ; 2013 May; 346():f3025. PubMed ID: 23667128
    [No Abstract]   [Full Text] [Related]  

  • 23. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tonsillar and oral cancer should be considered in the discussion on HPV vaccine].
    Andersson G; Hasson BG; Rosenquist K; Schildt EB; Wennerberg J
    Lakartidningen; 2007 Jan 24-30; 104(4):257-8; author reply 258-9. PubMed ID: 17328475
    [No Abstract]   [Full Text] [Related]  

  • 25. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Torres-Román JS; Montenegro-Idrogo JJ
    Salud Publica Mex; 2017; 59(1):1-2. PubMed ID: 28423098
    [No Abstract]   [Full Text] [Related]  

  • 27. HPV-linked oral cancer: another argument for universal HPV vaccination of boys and girls.
    Laurence J
    AIDS Read; 2008 Jul; 18(7):345-6. PubMed ID: 18655309
    [No Abstract]   [Full Text] [Related]  

  • 28. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
    Parkin DM; Louie KS; Clifford G
    Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia.
    Shefer A; Markowitz L; Deeks S; Tam T; Irwin K; Garland SM; Schuchat A
    Vaccine; 2008 Aug; 26 Suppl 10():K68-75. PubMed ID: 18847559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks.
    Anderson RS
    J Miss State Med Assoc; 2008 Dec; 49(12):385-6. PubMed ID: 19297935
    [No Abstract]   [Full Text] [Related]  

  • 31. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology behind the HPV vaccine discovery.
    Koutsky L
    Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes of Arkansas' primary care physicians toward the HPV vaccine.
    Tariq S; Bhakta S; Grimes A; Stevens A
    J Ark Med Soc; 2009 Nov; 106(5):113-7. PubMed ID: 19899297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Merck hopes to extend gardasil vaccine to men.
    Chitale R
    J Natl Cancer Inst; 2009 Feb; 101(4):222-3. PubMed ID: 19211446
    [No Abstract]   [Full Text] [Related]  

  • 36. Anal pap screening in men with HIV.
    Raper JL
    Adv Nurse Pract; 2006 Jun; 14(6):30-5; quiz 36. PubMed ID: 16972456
    [No Abstract]   [Full Text] [Related]  

  • 37. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus, cervical cancer prevention, and more.
    Lowy D
    Vaccine; 2008 Aug; 26 Suppl 10():iii-iv. PubMed ID: 18847562
    [No Abstract]   [Full Text] [Related]  

  • 39. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
    Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
    Mennini FS; Giorgi Rossi P; Palazzo F; Largeron N
    Gynecol Oncol; 2009 Feb; 112(2):370-6. PubMed ID: 19041125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.